Naltrexone versus acamprosate in the relapse prevention of alcoholism: A randomized placebo controlled trial

被引：0
|
作者：
Kiefer, F [1 ]
Jahn, H [1 ]
Briken, P [1 ]
Kampf, P [1 ]
Holzbach, R [1 ]
Naber, D [1 ]
Wiedemann, K [1 ]
机构：
[1] Univ Hamburg, Dept Psychiat, D-20246 Hamburg, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [31] Omega-3 for the Prevention of Alcohol Use Disorder Relapse: A Placebo-Controlled, Randomized Clinical Trial
    Pauluci, Renata
    Noto, Ana Regina
    Curado, Daniela Fernandez
    Siqueira-Campos Jr, Miguel
    Bezerra, Andreia Gomes
    Fernandes Galduroz, Jose Carlos
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [32] Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial
    Mann, K
    Ackermann, K
    Diehl, A
    Ebert, D
    Mundle, G
    Nakovics, H
    Reker, T
    Richter, G
    Schmidt, LG
    Driessen, M
    Rettig, K
    Opitz, K
    Croissant, B
    PSYCHOPHARMACOLOGY, 2006, 184 (01) : 115 - 121
  • [33] Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial
    K. Mann
    K. Ackermann
    A. Diehl
    D. Ebert
    G. Mundle
    H. Nakovics
    T. Reker
    G. Richter
    L. G. Schmidt
    M. Driessen
    K. Rettig
    K. Opitz
    B. Croissant
    Psychopharmacology, 2006, 184 : 115 - 121
  • [34] Continuation Electroconvulsive Therapy With Pharmacotherapy Versus Pharmacotherapy Alone for Prevention of Relapse of Depression A Randomized Controlled Trial
    Nordenskjold, Axel
    von Knorring, Lars
    Ljung, Tomas
    Carlborg, Andreas
    Brus, Ole
    Engstrom, Ingemar
    JOURNAL OF ECT, 2013, 29 (02) : 86 - 92
  • [35] Lupus atherosclerosis prevention study (LAPS): A randomized double blind placebo controlled trial of atorvastatin versus placebo.
    Petri, Michelle
    Kiani, Adnan N.
    Post, Wendy
    Magder, Laurence
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S520 - S520
  • [36] Lofexidine in Combination with Oral Naltrexone for Opioid Use Disorder Relapse Prevention: A pilot Randomized, Double-Blind, Placebo-Controlled Study
    Hermes, Gretchen
    Hyman, Scott M.
    Fogelman, Nia
    Kosten, Thomas R.
    Sinha, Rajita
    AMERICAN JOURNAL ON ADDICTIONS, 2019, 28 (06): : 480 - 488
  • [37] The cost effectiveness of acamprosate in the treatment of alcoholism in Germany:: economic evaluation of the prevention of relapse with acamprosate in the management of alcoholism (PRAMA) study (vol 13, pg 710, 1998)
    Schädlich, PK
    Brecht, JG
    PHARMACOECONOMICS, 2000, 17 (01) : 69 - 69
  • [38] CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPY
    Jarosz, J.
    Miernik, K.
    Wachal, M.
    Walczak, J.
    VALUE IN HEALTH, 2011, 14 (03) : A187 - A188
  • [39] A randomized controlled trial of quetiapine versus placebo in the treatment of delirium
    Tahir, Tayyeb
    Eeles, Eamonn
    Reddy, Venu
    Adeymo, Toyin
    Muthuvelu, Prem
    Chapple, Sian
    Phillps, Bethan
    Bisson, Jonathan
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (06) : 677 - 677
  • [40] A randomized controlled trial of quetiapine versus placebo in the treatment of delirium
    Tahir, Tayyeb A.
    Eeles, Eamonn
    Karapareddy, Venugopal
    Muthuvelu, Prem
    Chapple, Sian
    Phillips, Bethan
    Adyemo, Toyin
    Farewell, Daniel
    Bisson, Jonathan I.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2010, 69 (05) : 485 - 490
12345